BCLI — Brainstorm Cell Therapeutics Share News
0.000.00%
Last trade - 00:00Brainstorm Cell Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brainstorm Cell Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Brainstorm Cell Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Brainstorm Cell Therapeutics To Provide Corporate Update On Phase 3b Trial At The 2024 Maxim Healthcare Virtual Summit
Brief: Brainstorm Cell Therapeutics Approves One-For-Fifteen Reverse Stock Split Of Co's Common Stock
Brainstorm Cell Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Brainstorm Cell Therapeutics Q2 net income USD -2.5 million
Brainstorm Cell Therapeutics Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Brainstorm Cell Therapeutics Inc Says On July 18, Co Received MVLS Deficiency Notice From The Listing Qualifications Department Staff Of Nasdaq
Brief: Brainstorm Cell Therapeutics Announces Pricing Of $4.0 Million Registered Direct Offering
Brief: Brainstorm Cell Therapeutics Reaches Alignment With FDA On CMC Aspects Of Phase 3b NurOwn® Clinical Trial
Brief: BrainStorm Cell Therapeutics Appoints Haro Hartounian As Chief Operating Officer
Brainstorm Cell Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Brainstorm Cell Therapeutics Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement By April 29
Brief: BrainStorm Cell Therapeutics Regains Compliance With Nasdaq Minimum Market Value Rule
Brief: Brainstorm Cell Therapeutics Announces Peer-Reviewed Publication Of Biomarker Data From NurOwn's Phase 3 Clinical Trial In ALS
U.S. STOCKS ON THE MOVE-Chemours, Lucid, OppFi
U.S. STOCKS ON THE MOVE-Digital Realty, Alphabet, Moderna
U.S. STOCKS ON THE MOVE-Bloom Energy, Hecla Mining, Alkermes